标题/作者	年份
Dementia prevention, intervention, and care: 2020 report of the Lancet Commission G Livingston, J Huntley, A Sommerlad, D Ames, C Ballard, S Banerjee, ... The Lancet 396 (10248), 413-446	2020
Alzheimer's disease JAS Lopez, HM González, GC Léger Handbook of clinical neurology 167, 231-255	2019
Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group B Dubois, N Villain, GB Frisoni, GD Rabinovici, M Sabbagh, S Cappa, ... The Lancet Neurology 20 (6), 484-496	2021
Biomarkers for neurodegenerative diseases O Hansson Nature medicine 27 (6), 954-963	2021
Interpretation of risk loci from genome-wide association studies of Alzheimer's disease SJ Andrews, B Fulton-Howard, A Goate The Lancet Neurology 19 (4), 326-335	2020
Associations of amyloid, tau, and neurodegeneration biomarker profiles with rates of memory decline among individuals without dementia CR Jack, HJ Wiste, TM Therneau, SD Weigand, DS Knopman, MM Mielke, ... Jama 321 (23), 2316-2325	2019
Biological subtypes of Alzheimer disease: A systematic review and meta-analysis D Ferreira, A Nordberg, E Westman Neurology 94 (10), 436-448	2020
Cryo-EM structures of four polymorphic TDP-43 amyloid cores Q Cao, DR Boyer, MR Sawaya, P Ge, DS Eisenberg Nature structural & molecular biology 26 (7), 619-627	2019
Phase separation and neurodegenerative diseases: a disturbance in the force A Zbinden, M Pérez-Berlanga, P De Rossi, M Polymenidou Developmental cell 55 (1), 45-68	2020
The probabilistic model of Alzheimer disease: the amyloid hypothesis revised GB Frisoni, D Altomare, DR Thal, F Ribaldi, R van der Kant, ... Nature Reviews Neuroscience 23 (1), 53-66	2022
The path forward in Alzheimer's disease therapeutics: Reevaluating the amyloid cascade hypothesis M Tolar, S Abushakra, M Sabbagh Alzheimer's & Dementia	2019
Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study EH Thijssen, R La Joie, A Strom, C Fonseca, L Iaccarino, A Wolf, S Spina, ... The Lancet Neurology 20 (9), 739-752	2021
TDP-43 proteinopathies: a new wave of neurodegenerative diseases EMJ De Boer, VK Orie, T Williams, MR Baker, HM De Oliveira, ... Journal of Neurology, Neurosurgery & Psychiatry 92 (1), 86-95	2021
HSP70 chaperones RNA-free TDP-43 into anisotropic intranuclear liquid spherical shells H Yu, S Lu, K Gasior, D Singh, S Vazquez-Sanchez, O Tapia, D Toprani, ... Science 371 (6529), eabb4309	2021
TDP-43 represses cryptic exon inclusion in the FTD–ALS gene UNC13A XR Ma, M Prudencio, Y Koike, SC Vatsavayai, G Kim, F Harbinski, ... Nature 603 (7899), 124-130	2022
Molecular pathology of neurodegenerative diseases: principles and practice GG Kovacs Journal of clinical pathology 72 (11), 725-735	2019
The role of TDP-43 propagation in neurodegenerative diseases: integrating insights from clinical and experimental studies M Jo, S Lee, YM Jeon, S Kim, Y Kwon, HJ Kim Experimental & molecular medicine 52 (10), 1652-1662	2020
The bivariate distribution of amyloid-β and tau: relationship with established neurocognitive clinical syndromes CR Jack Jr, HJ Wiste, H Botha, SD Weigand, TM Therneau, DS Knopman, ... Brain 142 (10), 3230-3242	2019
FUS and TDP-43 phases in health and disease B Portz, BL Lee, J Shorter Trends in biochemical sciences 46 (7), 550-563	2021
Phase separation-deficient TDP43 remains functional in splicing HB Schmidt, A Barreau, R Rohatgi Nature communications 10 (1), 4890	2019

1 - 20

计算机程序会自动估算并确定日期和引用次数。